Arteslide M Tablet contains Artesunate 100mg and Mefloquine 220mg, a WHO-recommended antimalarial combination for managing acute uncomplicated malaria. This dual therapy works rapidly to clear parasites from the bloodstream and deliver a sustained action to prevent recurrence. Artesunate acts quickly to reduce parasite load, while Mefloquine provides extended protection, making the combination highly effective in endemic regions.
The formulation is designed for improved absorption, consistent potency, and dependable therapeutic efficiency. Its effectiveness against resistant malaria strains makes it a preferred choice among healthcare professionals, especially in high-risk areas where recurrent malaria episodes are common. With strong clinical backing, this combination ensures faster recovery and reduced chances of treatment failure.
From a business perspective, Arteslide M Tablet offers massive demand in rural, semi-urban, and tropical regions where malaria cases peak seasonally. Antimalarials are a must-have category for every pharmacy, government tender supplier, and general medicine distributor, making this product a steady mover with assured year-round requirements.
Adding Arteslide M to your distribution line strengthens your presence in the infectious disease segment. It ensures consistent orders from clinics, hospitals, and healthcare centers while offering excellent growth potential through bulk supply, franchise distribution, third-party manufacturing, and export channels. This makes it a profitable and strategic product for expanding your antimalarial portfolio.